AI assistant
CAMBRIDGE NUTRITIONAL SCIENCES PLC — Director's Dealing 2018
Apr 23, 2018
7544_dirs_2018-04-23_294739f5-4eaa-4db4-9536-c242aa85f3b8.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7548L
Omega Diagnostics Group PLC
23 April 2018
Omega Diagnostics Group PLC
("Omega" or the "Company")
Director/ PDMR Dealing
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it was notified on 23 April 2018 that Kieron Harbinson, Group Finance Director of the Company has purchased 125,000 ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares") at a volume weighted average price of 13.05 pence per Ordinary Share.
Following the purchase of these shares Mr Harbinson will be interested in 606,617 Ordinary Shares of the Company, representing approximately 0.48 per cent. of the Company's issued share capital.
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
1)
Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)
Name
Kieron Harbinson
2.
Reason for notification
b)
Position / status
Group Finance Director
c)
Initial notification / amendment
Initial Notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)
Name
Omega Diagnostics Group plc
c)
LEI
2138007U9P4BTZTYIR92
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Identification code
Purchase of Ordinary Shares
GB00B1VCP282
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
| Volume(s) | Price(s) £ |
| 50,000 | 0.125 |
| 25,000 | 0.134 |
| 50,000 | 0.134 |
d)
Aggregated information
Aggregated volume Price
| Aggregate Volume(s) | Volume weighted average Price) £ |
| 125,000 | 0.1305 |
e)
Date of the transaction
23/04/18
f)
Place of the transaction
LSE
Contacts:
| Omega Diagnostics Group PLC | Tel: 01259 763 030 |
| Colin King, Chief Executive | www.omegadiagnostics.com |
| Kieron Harbinson, Group Finance Director | |
| Jag Grewal, Group Sales and Marketing Director | |
| finnCap Ltd | Tel: 020 7220 0500 |
| Geoff Nash/James Thompson (Corporate Finance) | |
| Camille Gochez (Corporate Broking) | |
| Walbrook PR Limited | Tel: 020 7933 8780 or [email protected] |
| Paul McManus | Mob: 07980 541 893 |
| Lianne Cawthorne | Mob: 07584 391 303 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGIGDSCDDBGIX